Can a simple numbing drug make heart ablation less disruptive?

NCT ID NCT07354217

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether giving lidocaine through an IV can reduce diaphragm twitching and coughing during a procedure called pulse field ablation for atrial fibrillation. Sixty adults with AFib will be randomly assigned to receive lidocaine or a placebo (saline). The goal is to see if lidocaine makes the procedure smoother and more comfortable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lidocaine
What this could lead to
If it works, this could make pulse field ablation more comfortable and reduce procedure interruptions for atrial fibrillation patients.
What could go wrong
This is a small Phase 4 study (60 people) testing a known drug for a new use during a procedure. It may not show clear benefit, and lidocaine can have side effects like low blood pressure or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Taiwan University Hospita

    Taipei, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.